Victoria's Secret Earnings Surge on Bra Sales

Victoria's Secret earnings beat and the company raised fiscal 2026 guidance on June 2, 2026; stronger bra demand and margin gains may drive buyback flows.

June 02, 2026·2 min read
View all news articles
Flat-vector lingerie storefront with an expanding margin ribbon to symbolize Victoria's Secret earnings turnaround.

KEY TAKEAWAYS

  • Q1 net sales $1.6 billion, up 15.0%, adjusted EPS $0.60 and GAAP net income $48 million.
  • Company raised fiscal 2026 guidance to $7.0-$7.1 billion and adjusted operating income to $550-$580 million.
  • Repurchased 2.2 million shares for $100 million, with $150 million remaining under authorization.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Victoria’s Secret & Co. (VSCO) reported first-quarter results on June 2, 2026, that exceeded expectations and prompted a full-year guidance raise. The company cited broad-based lingerie demand, particularly strong bra sales, margin gains, and operational discipline as key drivers, while leaving room under its share-repurchase authorization.

Quarter Results and Drivers

For the quarter ended May 2, 2026, Victoria’s Secret reported net sales of $1.56 billion, up 15% year over year and above prior guidance of $1.49–$1.53 billion. Comparable sales rose 13%. GAAP operating income increased to $76 million from $20 million a year earlier, and GAAP net income attributable to the company swung to $47.7 million from a $1.7 million loss, producing GAAP diluted earnings per share (EPS) of $0.56. On an adjusted basis, operating income was $80.1 million, net income $50.5 million, and EPS $0.60.

Management attributed the results to broad-based demand, especially strong bra and core lingerie sales across Victoria’s Secret, PINK, and Beauty brands. Higher average selling prices, reduced promotional activity, broad gross-margin gains, and selling, general, and administrative (SG&A) leverage supported profitability. The company also benefited from lower-than-expected tariff costs. This marked the fourth consecutive quarter of sales growth.

Guidance and Capital Allocation

Victoria’s Secret raised its fiscal 2026 guidance to consolidated net sales of $7.03–$7.13 billion, up from $6.85–$6.95 billion, and adjusted operating income to $550–$580 million from $430–$460 million. Adjusted EPS guidance now ranges from $4.35 to $4.60, implying substantially higher profitability than the prior year’s adjusted operating income of $403 million.

The company repurchased 2.2 million shares in the quarter for $100 million at an average price of $45.27, leaving $150 million available under its $250 million repurchase authorization. The Q1 disclosures included no dividend changes, mergers or acquisitions, or regulatory notices.

Victoria’s Secret’s adjusted EPS materially exceeded consensus estimates, which clustered near $0.29–$0.30, representing an earnings surprise of about 109%. Revenue also topped estimates. The updated full-year outlook surpasses recent analyst models and will likely prompt revisions.

Management highlighted sustained momentum in core categories, particularly bras, elevated selling prices, reduced promotional intensity, and ongoing operational discipline as the basis for its outlook. This signals a test of durability for the turnaround as investors and analysts adjust to the raised guidance.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Dollar General Earnings Lift Full-Year Outlook

Dollar General Earnings Lift Full-Year Outlook

Dollar General earnings showed margin expansion and steady comps, and the company raised fiscal 2026 EPS guidance, signaling margin-led upside for traders.

Marvell Stock Surges After Nvidia CEO Endorsement

Marvell Stock Surges After Nvidia CEO Endorsement

Marvell stock jumped after Jensen Huang's Computex endorsement, spotlighting AI interconnects and Nvidia's $2 billion stake amid valuation questions.

Abivax Obefazimod Trial Shows Strong Remission; Stock Drops

Abivax Obefazimod Trial Shows Strong Remission; Stock Drops

Abivax obefazimod trial showed large maintenance remission gains but reported malignancies sparked a sharp sell-off and raised regulatory uncertainty.

Credo Technology Q4 Earnings Surge, Margins Slip

Credo Technology Q4 Earnings Surge, Margins Slip

Credo Technology Q4 earnings beat with $437 million revenue on AI demand; guidance signaled lower near-term margins and triggered after-hours selling.

Alphabet $80 Billion Equity Raise Includes Berkshire Stake

Alphabet $80 Billion Equity Raise Includes Berkshire Stake

Alphabet $80 Billion Equity Raise to fund AI infrastructure includes a $10 billion Berkshire stake, prompting trading focus on dilution and placement.

HPE Q2 Earnings Lift Outlook on AI, Networking

HPE Q2 Earnings Lift Outlook on AI, Networking

HPE Q2 earnings reported a record quarter as HPE pulled forward 2028 targets and raised its outlook, prompting investor flows into AI and networking.